Calendar Bellerophon Therapeutics, Inc.

Equities

BLPH

US0787713009

Market Closed - OTC Markets 02:10:41 2024-04-26 pm EDT 5-day change 1st Jan Change
0.0554 USD +0.73% Intraday chart for Bellerophon Therapeutics, Inc. +1.84% +49.73%

Chart calendar Bellerophon Therapeutics, Inc.

93b4e14c6a3a785fdd.UcqWMN3x4YP_-ZhFa643xG7AKAQyODbGs_0_0GDkfFY.FPP8BOXJ0faVjK0rNNoElQW4UFt7SnOvwptMhDLRMx8i_sVhuabQ5ZmOzQ~e964ab70e3295d034dd024970f2f9f4d

Upcoming events on Bellerophon Therapeutics, Inc.

2024-05-08 Q1 2024 Earnings Release (Projected)

Past events on Bellerophon Therapeutics, Inc.

2024-03-01 11:00 am Extraordinary Shareholders Meeting - Restructuring Vote
2023-06-06 Annual General Meeting
2023-06-05 08:30 am INOpulse Phase 3 Clinical Trial Results Call
2023-05-15 04:50 pm Q1 2023 Earnings Release
2023-03-31 08:30 am Q4 2022 Earnings Release
2022-11-14 08:30 am Q3 2022 Earnings Release
2022-08-15 08:30 am Interim 2022 Earnings Release
2022-06-01 10:00 am Annual General Meeting
2022-05-17 05:15 pm American Thoracic Society International Conference
2022-05-11 08:30 am Q1 2022 Earnings Release
2022-03-31 04:01 pm FY 2021 Earnings Release
2022-01-10 07:00 am H.C. Wainwright BioConnect Conference
2022-01-04 LifeSci Partners Corporate Access Event
2021-11-15 08:30 am Q3 2021 Earnings Release
2021-09-13 08:00 am H.C. Wainwright Global Investment Conference
2021-08-05 08:30 am Interim 2021 Earnings Release
2021-06-03 03:00 pm Jefferies Healthcare Conference
2021-05-25 Annual General Meeting
2021-05-11 08:30 am Q1 2021 Earnings Release
2021-03-11 08:30 am FY 2020 Earnings Release

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-27,9
-31,6
11.75%
-17,5
-18,1
3.55%
-26,3
-26,8
1.92%
-20,2
-21,4
5.57%
-22,4
-22,4
0.05%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-2,63
-10,0
73.78%
-15,1
-15,9
5.24%
-26,9
-27,4
2.12%
-19,6
-20,7
5.71%
-22,2
-22,3
0.05%
Net income
Million USD
Released
Forecast
Spread
2,81
-4,57
161.52%
-13,3
-14,1
5.92%
-24,7
-26,0
4.95%
-17,8
-18,9
6.25%
-19,8
-19,9
0.35%
EPS
USD
Released
Forecast
Spread
0,65
-1,20
154.08%
-2,95
-3,00
1.67%
-3,17
-3,34
5.09%
-1,87
-1,94
3.61%
-2,08
-2,03
-2.72%
Announcement Date14/03/1906/04/2011/03/2131/03/2231/03/23

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
5,64
0,00
-
0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-4,80
-6,32
23.94%
-4,27
-5,46
21.74%
-5,64
-5,25
-7.57%
-6,54
-5,79
-12.97%
-5,12
-6,25
18.08%
-5,09
-5,15
1.17%
1,48
-5,78
125.57%
-5,26
-4,40
-19.6%
-2,17
-4,60
52.83%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-4,63
-6,32
26.62%
-4,27
-5,46
21.76%
-5,64
-5,25
-7.55%
-6,52
-5,79
-12.74%
-5,07
-6,25
18.83%
-5,02
-5,15
2.51%
1,55
-5,75
126.85%
-5,14
-4,34
-18.47%
-1,92
-4,58
58.03%
Net income
Million USD
Released
Forecast
Spread
-4,63
-6,32
26.62%
-4,27
-5,46
21.76%
-5,64
-5,25
-7.55%
-4,11
-5,79
29.04%
-5,07
-6,25
18.83%
-5,02
-5,15
2.51%
2,82
-5,19
154.4%
-5,14
-4,34
-18.47%
-1,92
-4,58
58.03%
EPS
USD
Released
Forecast
Spread
-0,49
-0,63
22.22%
-0,45
-0,52
13.46%
-0,59
-0,55
-8.26%
-0,43
-0,61
28.93%
-0,53
-0,59
9.4%
-0,53
-0,48
-10.42%
0,27
-0,49
155.1%
-0,42
-0,42
0%
-0,16
-0,44
63.64%
Announcement Date15/11/2131/03/2211/05/2215/08/2214/11/2231/03/2315/05/2314/08/2314/11/23

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BLPH Stock
  4. Calendar Bellerophon Therapeutics, Inc.